{
  "docId": "019de072-7781-7512-96cc-a2b05ce755c7",
  "docSlug": "b1746432eb5f270eac90273cddb862aa",
  "documentTitle": "Bionomics | Investor Presentation Deck | 38 slides",
  "authorId": "bionomics",
  "authorName": "Bionomics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 38,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "traction",
  "function": "show_traction",
  "density": "overcrowded",
  "nDataPoints": 6,
  "notes": "Includes fMRI and behavioral task data from a 4-way crossover study.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/10",
  "deckHref": "/decks/019de072-7781-7512-96cc-a2b05ce755c7",
  "deckJsonHref": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json",
  "deckAnchorHref": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.85,
        "x": 0.07,
        "y": 0.75
      },
      "kind": "callout",
      "text": "Amygdala activation is an imaging surrogate for anxiety. Connectivity between the amygdala and Anterior Cingulate Cortex (ACC) is very strong in high anxiety.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3bef5b0e-ff47-4b2f-b322-c746c63482df",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.2,
        "x": 0.35,
        "y": 0.45
      },
      "kind": "chart",
      "text": "Amygdala activation (L & R) for Placebo vs 300mg",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3210a246-bac6-4282-bf5c-eda04ff252a2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.65,
        "y": 0.45
      },
      "kind": "chart",
      "text": "Mean Intensity of Defensive Behavior across 4 treatment arms",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eeea83b9-a682-43c0-9aa0-d7827d5c53c2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.85,
        "x": 0.08,
        "y": 0.1
      },
      "kind": "diagram",
      "text": "4-way crossover study design: 24 GAD patients, 4 treatment arms, fearful faces task, JORT task, fMRI monitoring.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ca49ca7c-71ec-45b7-ab67-03a6ee633e57",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.5,
        "x": 0.13,
        "y": 0.88
      },
      "kind": "disclaimer",
      "text": "Wise T. et al., Biological Psychiatry 2020; Perkins A. et al., Translational Psychiatry 2021. GAD = Generalized Anxiety Disorder, JORT = Joystick Operated Runway Task, fMRI = Functional Magnetic Resonance Imaging",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d010fac1-3b33-4cea-9d44-60cd157728ad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.08,
        "y": 0.45
      },
      "kind": "image",
      "text": "Brain scan showing amygdala activation",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "28f60373-9931-4532-9b1a-907ee590d182",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.07,
        "y": 0.03
      },
      "kind": "title",
      "text": "BNC210 Demonstrated Acute Anxiolytic Activity in GAD Phase 2",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0e127bb8-a96e-4659-a801-0a78855fb9c9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 9,
      "beatId": "50748b04-b9b4-4fc9-8bc4-af166cf1058b",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "Traction is presented on pages 9-10, showcasing BNC210's efficacy in reducing panic symptoms and demonstrating acute anxiolytic activity.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 9,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "5449b11f-140a-484b-a6d0-f26616247fcf",
      "evidence": "The traction section on pages 9-10 presents BNC210's efficacy in reducing panic symptoms and demonstrating acute anxiolytic activity.",
      "position": 2,
      "objective": "Can BNC210 provide a quick win in treating anxiety disorders?",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}